2017
DOI: 10.2174/1871527315666161018122909
|View full text |Cite
|
Sign up to set email alerts
|

Differentiation of Glioblastoma and Lymphoma Using Feature Extraction and Support Vector Machine

Abstract: Differentiation of glioblastoma multiformes (GBMs) and lymphomas using multi-sequence magnetic resonance imaging (MRI) is an important task that is valuable for treatment planning. However, this task is a challenge because GBMs and lymphomas may have a similar appearance in MRI images. This similarity may lead to misclassification and could affect the treatment results. In this paper, we propose a semi-automatic method based on multi-sequence MRI to differentiate these two types of brain tumors. Our method con… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
9
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(9 citation statements)
references
References 0 publications
0
9
0
Order By: Relevance
“…Our results were also comparable to other prior studies that also evaluated the utility of texture analysis to differentiate glioblastoma from PCNSL (Supplemental Table 2). 2,20,[22][23][24][25][26][27][28][29][30][31] The higher performance of Kim et al 23 (AUC 0.956) and Nakagawa et al 25 (AUC 0.980) may be secondary to texture feature extraction from multiparametric images including three-dimensional (3D) T1 CE sequence, T2-weighted and diffusion-weighted images. In contrast, we performed texture analysis on a routinely acquired 2D T1 CE sequence which is performed universally.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Our results were also comparable to other prior studies that also evaluated the utility of texture analysis to differentiate glioblastoma from PCNSL (Supplemental Table 2). 2,20,[22][23][24][25][26][27][28][29][30][31] The higher performance of Kim et al 23 (AUC 0.956) and Nakagawa et al 25 (AUC 0.980) may be secondary to texture feature extraction from multiparametric images including three-dimensional (3D) T1 CE sequence, T2-weighted and diffusion-weighted images. In contrast, we performed texture analysis on a routinely acquired 2D T1 CE sequence which is performed universally.…”
Section: Discussionmentioning
confidence: 99%
“…Our results were also comparable to other prior studies that also evaluated the utility of texture analysis to differentiate glioblastoma from PCNSL (Supplemental Table 2). 2,20,2231…”
Section: Discussionmentioning
confidence: 99%
“…The feature selection and model-building methods vary significantly among studies (see Table S1), and in some cases, the models include clinical or semantic variables. MRI sequences used for tumor differentiation vary as well and have, for example, CE T1 sequences only [46,52,54] as well as combinations of ADC and T1CE [55]; ADC, FLAIR, and CE T1 [47]; DWI, CE T1, and FLAIR [48]; CE T1, T2 and DWI [50]; T1, T2, and FLAIR [51,56]; or ADC and gradientecho [15]. A study involving 141 patients reported over 90% accuracy in differentiation between various tumor entities, including GBM, lymphoma, BM, and meningioma, using five MRI sequences in total [15].…”
Section: Primary Cns Lymphomamentioning
confidence: 99%
“…The authors could identify two features that enabled the discrimination between these two entities with a very high accuracy. Alternatively to the conventional approach of tumor volumetry, a representative axial slice can be used to draw a region of interest and differentiate between GBM and lymphoma with high accuracy [56]. Despite the considerable heterogeneity of these approaches, it seems that radiomics is a promising tool for the differentiation of lymphoma and GBM, as evidenced by a satisfactory AUC in some of these models.…”
Section: Primary Cns Lymphomamentioning
confidence: 99%
“…1). 1,5,12,19,33,[36][37][38] Overall, 6 (75%) of the studies exclusively compared GBM to PCNSL, and 2 of the studies included other tumors as well ( Table 2). All studies only investigated de novo tumors that were imaged using T1-/T2-weighted MRI, FLAIR, and/or diffusion-weighted MRI prior to steroid administration, biopsy, or any other treatment.…”
Section: Systematic Reviewmentioning
confidence: 99%